Asbestos Now

Actos Bladder Cancer Lawsuits : The incidence of bladder cancer has risen over the past 20 years. Currently, around 54 500 new cases of bladder cancer are diagnosed in the USA each year, and 15 000 cases in the UK. Bladder cancer is the fourth most common cancer in men in the USA and the tenth most common in women. It is one of the most frequent causes of cancer death, accounting for about 10 000 deaths annually in the USA and 5000 in the UK.

More information on Actos Bladder Cancer Lawsuits

The incidence of bladder cancer varies among different patient groups. For example, there is a 3:1 male-to-female ratio, though the prevalence among women appears to be rising.

The incidence is higher in elderly populations, with a median age at presentation of 60-65 years. No evidence exists for a familial or inherited pattern among any patient group, although occasional family clusters have been recorded. In black people the incidence is lower than in white people; in Asian races it appears to be intermediate. The lifetime risk of developing bladder cancer is:

• 2.8% for white men
• 0.9% for black men
• 1.0% for white women
• 0.6% for black women.

Information from other sources on Actos Bladder Cancer Lawsuits

Five-year survival for both black and white people during the period 1986-92 (60% and 82%, respectively) was significantly better than the equivalent rates for 1974-76 (47% and 74%, respectively; p < 0.05). It is not really known why there are substantial ethnic differences in incidence and prognosis, although putative factors include differences in diet and nutritional status, differences in gene expression (especially of enzymes that may metabolize carcinogens) and differential access to healthcare.

Our use of the term or terms Actos Bladder Cancer Lawsuits is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on (keyword) visit our site often.

Actos Bladder Cancer Lawsuits

Actos Bladder Cancer Lawsuits : Those patients in the highest quintile of fluid intake (>2531 mL/day) had a 49% lower incidence of BC than those in lowest quintile (<1290 mL/day). This relation between fluid intake and BC was observed among smokers’ patients as well as among nonsmokers. This suggested to the authors that residual confounding by smoking is unlikely to be responsible for their results.An explanation for the decrease in risk of BC with increase on fluid intake could be that high fluid intake could dilute the concentration of carcinogens in urine or reduce the contact of those carcinogens with urothelium by increasing the voiding frequency. However, it had been postulated that contrary to that supposed, high fluid intake could increase the risk of BC if that fluid contents contain contaminants that are bladder carcinogens. In that way, a pooled analysis of six case-control studies of BC with detailed information on fluid intake and water pollutants were reported. The pooled study included 2729 cases and 5150 controls from studies performed at the Untied States, Canada, Finland, France, and Italy between 1978 and 2000. They found an increased risk of BC for tap water consumption, and this was consistently found in the six studies analyzed. A total tap water intake more than 2.01 L/day increased the risk of BC in 50% compared to total tap water ingestion less than 0.5 L/day. The association of tap water ingestion but not with nontap water fluids suggested to the authors that the increased risk observed in tap water intake was related to carcinogens diluted in such type of fluids (Villanueva et al. 2006).

More information on Actos Bladder Cancer Lawsuits

Due to controversial results obtained in different epidemiological studies, further studies will be necessary to establish the real influence of fluid intake in BC risk.Other dietary factors had been related to BC. A prospective study of atomic bomb survivors showed that green-yellow-vegetable and fruit consumption were significantly associated with decreased relative risk for BC. The study included 39,824 survivors of atomic bomb from 93,000 who have been under continuous surveillance by the Radiation Effects Research Foundation since 1950. They could observe that a frequency in green-yellow vegetable more than five times per week

Information from other sources on Actos Bladder Cancer Lawsuits

With opposite results, it was reported by The Health Professionals Follow-up Study, which is, as well as NLCS, a prospective cohort study. It started in 1986 with 51,529 male health professionals aged 40-75 years from all 50 states of the United States. Of these 47,909 men were eligible for follow-up, and the follow-up rate averaged at 94% per follow-up cycle during the five biennial cycles between 1986 and 1996. They diagnosed 252 new cases of BC, and age and smoking were the two major risk factors related to cancer. Interestingly, and contrary to NLCS, they found that daily water consumption had a protective effect in risk of BC. In that way, when fluid intake was considered as a continuous variable the risk of BC decreased by 7% for every increment of 240 mL in daily fluid intake.Those patients in the highest quintile of fluid intake (>2531 mL/day) had a 49% lower incidence of BC than those in lowest quintile (<1290 mL/day). This relation between fluid intake and BC was observed among smokers’ patients as well as among nonsmokers. This suggested to the authors that residual confounding by smoking is unlikely to be responsible for their results.

Our use of the term or terms Actos Bladder Cancer Lawsuits is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Bladder Cancer Lawsuits visit our site often.

http://www.seedol.com

Actos Bladder Cancer Lawsuits : Although MRIs are wonderful tests that provide a great view of the urinary system, there are a few risks. If you have an aneurysm clip from a prior brain procedure, you must let your doctor know because this clip could become dislodged during the exam. No one with a cardiac pace­maker should have an MRI performed. If you have any type of implanted device such as an electrical stimulator or pump, you should not have an MRI performed. Pregnant women during the first trimester should not have an MRI; neither should metal or machine workers who may have a small fragment of metal in their eye. Contrast is sometimes given during MRI exams and patients rarely experience al­lergic reactions to it. MRI pros include detailed imaging and a lack of radiation. Its cons are its expense and patient discomfort due to claustrophobia.

More information on Actos Bladder Cancer Lawsuits

BLADDER CANCER GRADING AND STAGING

Cancer grade and stage are two terms you will most likely hear abotit during the course of treatment. Bladder cancer grade and stage are not the same and should not be used interchangeably to describe your cancer. Grade, expressed as a number, is used to describe the appearance of cells under the microscope and increases from i to 4 depending on how they look compared with normal cells. Grade of cancer refers to the aggressiveness of the disease. Grade 4 cancers are typically more aggressive than grade 1 cancers, and they recur more often. Cancer staging describes the extent or spread of the disease at the time of diagnosis. It is essential in determining the choice of therapy and in as­sessing prognosis. Cancer stage is based on the size and location of the primary tumor and whether it has spread to other areas of the body.

Information from other sources on Actos Bladder Cancer Lawsuits

The staging system used to describe bladder cancer in the United States was adopted by the American Joint Commit­tee on Cancer in 2002. It is often referred to as the “TNM staging system” and it assesses tumors in three ways: extent of the primary tumor (T), absence or presence of regional lymph node involvement (N), and absence or presence of distant métastasés (M). Please refer to Table 1-2 for a description of the various bladder cancer stages.

Our use of the term or terms Actos Bladder Cancer Lawsuits is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Bladder Cancer Lawsuits visit our site often.

http://www.seedol.com